| Financial Year |
March 31 2023 |
| Monetary Funds |
54,396,506.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
409,993.86 |
| Accounts Receivable |
177,099,639.65 |
| Advances to Suppliers |
34,507,971.45 |
| Other Receivables |
91,392,965.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
80,239,409.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
33,814,363.84 |
| Total Current Assets |
561,863,034.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
900,361,996.48 |
| Long-term Equity Investment |
343,157,290.26 |
| Investment Properties |
-- |
| Fixed Assetes |
264,181,313.78 |
| Under-construction Projects |
341,045,370.16 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
86,067,891.91 |
| R&D expenses |
-- |
| Goodwill |
131,354,619.61 |
| Long-Term Deferred and Prepaid Expenses |
3,644,968.34 |
| Deferred Income Tax Assets |
95,401,827.65 |
| Other Non-Current Assets |
851,314,097.42 |
| Sub-Total of Non-Current Assets |
3,040,016,356.51 |
| Total Assets |
3,601,879,391.39 |
| Short-Term Loans |
729,611,813.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
607,291,044.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,756,799.32 |
| Taxes Payable |
78,272,781.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
676,152,748.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
271,385,054.80 |
| Other Current Liabilities |
90,593,911.34 |
| Sub-Total of Current Liabilities |
2,576,582,448.73 |
| Long-term Loans |
724,953,129.85 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
41,367,974.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
134,168,845.23 |
| Deferred Income Tax Liabilities |
2,867,653.33 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
931,763,129.69 |
| Total Liabilities |
3,508,345,578.42 |
| Paid-In Capital(Or Share Stock) |
669,766,999.00 |
| Capital Surplus |
1,002,990,618.30 |
| Surplus Reserve |
52,990,089.66 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,556,785,923.02 |
| Minority Stockholder's Interest |
-83,155,433.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
176,689,246.72 |
| Owner's Equity（Stockholder's Equity） |
93,533,812.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,601,879,391.39 |
